Daiichi Sankyo
Qurish K Mohemmad holds advanced degrees including a Master in Management from Harvard University and a Master of Science in Biological Sciences/Biotechnology from the University of Massachusetts Lowell, along with a Bachelor of Pharmacy from Osmania University. Currently serving as the Director of Global Project Management & Leadership (Oncology) at Daiichi Sankyo, Inc., Qurish leads global project management for ENHERTU in gastric cancer and other oncology indications. Previous experience includes roles as Associate Director at Merck, Senior Manager at ARIAD Pharmaceuticals, and various positions in drug development and project management. Notable achievements include leading program teams for critical oncology drugs, managing alliances, and developing innovative techniques that enhanced operational efficiency in drug discovery and clinical development.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.